TGF-β signaling preserves RECK expression in activated pancreatic stellate cells

Journal of Cellular Biochemistry

Volumn 104, Issue 3, 2008, Pages 1065-1074

  Lee, Hongsik ^a   Lim, Chaeseung ^a   Lee, Jungeun ^b   Kim, Nayoung ^b   Bang, Sangsu ^b   Lee, Hojae ^c   Min, Bonhong ^b   Park, Gilhong ^b   Noda, Makoto ^d   Stetler Stevenson, William G ^e   Oh, Junseo ^b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Fibrosis; Pancreatic stellate cells; RECK; TGF

Indexed keywords

CERULETIDE; MATRIX METALLOPROTEINASE; MESSENGER RNA; PEPSTATIN; PROTEIN RECK; REGULATOR PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL LYSATE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME INHIBITION; EXTRACELLULAR MATRIX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STELLATE CELL;

ANIMALS; CELLS, CULTURED; COLLAGEN; GENE EXPRESSION REGULATION; MALE; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; PANCREAS; PEPSTATINS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS;

RATTUS;

EID: 45149083155     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21692     Document Type: Article

References (30)

1. Apte MV, Wilson JS. 2004. Mechanisms of pancreatic fibrosis. Dig Dis 22:273-279.
2. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. 1998. Periacinar stellate shaped cells in rat pancreas: Identification, isolation, and culture. Gut 43:128-133.
3. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A, Adler G. 1998. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115:421-432.
4. Benyon RC, Iredale JP. 2000. Is liver fibrosis reversible? Gut 46:443-446.
5. Eddy AA, Kim H, Lopez-Guisa J, Oda T, Soloway PD. 2000. Interstitial fibrosis in mice with overload proteinuria: Deficiency of TIMP-1 is not protective. Kidney Int 58:618-628.
6. Flanders KC. 2004. Smad3 as a mediators of the fibrotic response. Int J Exp Path 85:47-64.
7. Gauldie J, Kolb M, Ask K, Martin G, Bonniaud P, Warburton D. 2006. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc 3:696-702.
8. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DH, Pirola RC, McCaughan GW, Ramm GA, Wilson JS. 1999. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 155:1087-1095.
9. Hemmann S, Graf J, Roderfeld M, Roeb E. 2007. Expression of MMPs and TIMPs in liver fibrosis- a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46:955-975.
10. Jaster R. 2004. Molecular regulation of pancreatic stellate cell function. Mol Cancer 3:1-8.
11. Jiang Y, Goldberg ID, Shi YE. 2002. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21:2245-2252.
12. Kim H, Oda T, Lopez-Guisa J, Wing D, Edwards DR, Soloway PD, Eddy AA. 2001. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 12:736-748.
13. Kordes C, Brookmann S, Haussinger D, Klonowski-Stumpe H. 2005. Differential and synergistic effects of platelet-derived growth factor-BB and transforming growth factor-β1 on activated pancreatic stellate cells. Pancreas 31:156-167.
14. Krane SM, Byrne MH, Lemaitre V, Henriet P, Jeffrey JJ, Witter JP, Liu X, Wu H, Jaenisch R, Eeckhout Y. 1996. Different collagenase gene products have different roles in degradation of type I collagen. J Biol Chem 271:28509-28515.
15. Kruse M-L, Hildebrand PB, Timke C, Folsch UR, Schafer H, Schmidt WE. 2001. Isolation, long-term culture, and characterization of rat pancreatic fibroblastoid/stellate cells. Pancreas 23:49-54.
16. Noda M, Takahashi C. 2007. Reckless as a hallmark of aggressive cancer. Cancer Sci 98:1659-1665.
17. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. 2001. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107:789-800.
18. Oh J, Seo DW, Diaz T, Wei B, Ward Y, Ray JM, Morioka Y, Shi S, Kitayama H, Takahashi C, Noda M, Stetler-Stevenson WG. 2004. Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Res 64:9062-9069.
19. Oh J, Kim N, Seo S, Kim I-H. 2007. Alteration of extracellular matrix modulators after nonablative laser therapy in skin rejuvenation. Br J Dermatol 157:306-310.
20. Ohnishi H, Miyata T, Yasuda H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K, Makita N, Iiri T, Ueda N, Mashima H, Sugano K. 2004. Direct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-β1 regulation of pancreatic stellate cellular functions. J Biol Chem 279:8873-8878.
21. Phillips PA, McCarroll JA, Park S, Wu M-J, Pirola R, Korsten M, Wilson JS, Apte MV. 2003. Rat pancreatic stellate cells secrete matrix metalloproteinases. Gut 52:275-282.
22. Schiller M, Javelaud D, Mauviel A. 2004. TGF-β-induced SMAD signaling and gene regulation. J Dermatol Sci 35:83-92.
23. Schnabl B, Kweon YO, Frederick JP, Wang X, Rippe RA, Brenner DA. 2001. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34:89-100.
24. Shek FW, Benyon RC, Walker FM, McCrudden PR, Pender SL, Williams EJ, Johnson PA, Johnson CD, Bateman AC, Fine DR, Iredale JP. 2002. Expression of transforming growth factor-β1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol 160:1787-1798.
25. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M. 1998. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95:13221-13226.
26. Uemura M, Swenson ES, Gaca MD, Giordano FJ, Reiss M, Wells RG. 2005. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and α-smooth muscle actin organization. Mol Biol Cell 16:4214-4224.
27. Vaillant B, Chiaramonte MG, Cheever AW, Soloway PD, Wynn TA. 2001. Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: New insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol 167:7017-7026.
28. Verrecchia F, Mauviel A. 2002. Transforming growth factor-β signaling through the Smad pathway. J Invest Dermatol 118:211-215.
29. Vu TH, Werb Z. 2000. Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 14:2123-2133.
30. Wisdom R, Huynh L, Hsia D, Kim S. 2005. RAS and TGF-β exert antagonistic effects on extracellular matrix gene expression and fibroblast transforming. Oncogene 24:7043-7054.